TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $4.161B (100.0% shares, 0.0% debt)

Holdings (54)

New Positions (12)

ZLAB ZAI LAB LTD-ADR 2.8%
Value $117M Shares 6,137,627 Share Price $19.00 Est. Cost/Share — Unrealized @ Report Date —
AURA AURA BIOSCIENCES INC 1.6%
Value $67.69M Shares 9,533,333 Share Price $7.10 Est. Cost/Share — Unrealized @ Report Date —
TRAX FIRST TRACKS BIOTHERAPEUTICS 1.4%
Value $58.25M Shares 2,895,304 Share Price $20.12 Est. Cost/Share — Unrealized @ Report Date —
EDIT EDITAS MEDICINE INC 0.9%
Value $36M Shares 11,111,111 Share Price $3.24 Est. Cost/Share — Unrealized @ Report Date —
PHVS PHARVARIS BV 0.8%
Value $34.86M Shares 1,008,229 Share Price $34.58 Est. Cost/Share — Unrealized @ Report Date —
IFRX INFLARX N V 0.8%
Value $32.48M Shares 14,500,000 Share Price $2.24 Est. Cost/Share — Unrealized @ Report Date —
ALT ALTIMMUNE INC 0.7%
Value $30.4M Shares 10,000,000 Share Price $3.04 Est. Cost/Share — Unrealized @ Report Date —
AKTS AKTIS ONCOLOGY INC 0.5%
Value $22.45M Shares 696,560 Share Price $32.23 Est. Cost/Share — Unrealized @ Report Date —
FBRX FORTE BIOSCIENCES INC 0.5%
Value $19.55M Shares 920,000 Share Price $21.25 Est. Cost/Share — Unrealized @ Report Date —
RACC RESEARCH ALLIANCE CORP CL A 0.1%
Value $5.35M Shares 500,000 Share Price $10.70 Est. Cost/Share — Unrealized @ Report Date —
JATT JATT II ACQUISITION CORP 0.1%
Value $2.272M Shares 200,000 Share Price $11.36 Est. Cost/Share — Unrealized @ Report Date —
EIKN EIKON THERAPEUTICS INC 0.0%
Value $495K Shares 37,902 Share Price $13.05 Est. Cost/Share — Unrealized @ Report Date —

Increased Positions (2)

Exited Positions (7)

Decreased Positions (9)

Unchanged Positions (31)

SYRE SPYRE THERAPEUTICS INC 4.1%
Value $169M Shares 1,900,582 Share Price $88.78 Est. Cost/Share — Unrealized @ Report Date —
IMVT IMMUNOVANT INC 4.1%
Value $172M Shares 4,457,988 Share Price $38.53 Est. Cost/Share — Unrealized @ Report Date —
RLAY RELAY THERAPEUTICS INC 1.9%
Value $79.95M Shares 4,273,356 Share Price $18.71 Est. Cost/Share — Unrealized @ Report Date —
GLUE MONTE ROSA THERAPEUTICS INC 2.7%
Value $112M Shares 4,622,151 Share Price $24.20 Est. Cost/Share — Unrealized @ Report Date —
ADCT ADC THERAPEUTICS SA 0.3%
Value $12.19M Shares 11,390,175 Share Price $1.07 Est. Cost/Share — Unrealized @ Report Date —
MIRM MIRUM PHARMACEUTICALS INC 3.0%
Value $124M Shares 1,062,049 Share Price $117.07 Est. Cost/Share — Unrealized @ Report Date —
AMLX AMYLYX PHARMACEUTICALS INC 2.7%
Value $112M Shares 6,243,812 Share Price $17.96 Est. Cost/Share — Unrealized @ Report Date —
DNTH DIANTHUS THERAPEUTICS INC 3.9%
Value $163M Shares 1,676,624 Share Price $97.48 Est. Cost/Share — Unrealized @ Report Date —
TYRA TYRA BIOSCIENCES INC 2.5%
Value $104M Shares 3,248,980 Share Price $31.94 Est. Cost/Share — Unrealized @ Report Date —
DYN DYNE THERAPEUTICS INC 2.5%
Value $103M Shares 4,615,144 Share Price $22.21 Est. Cost/Share — Unrealized @ Report Date —
SLN SILENCE THERAPEUTICS PLC 0.8%
Value $33.31M Shares 3,033,560 Share Price $10.98 Est. Cost/Share — Unrealized @ Report Date —
MBX MBX BIOSCIENCES INC 0.9%
Value $35.88M Shares 650,000 Share Price $55.20 Est. Cost/Share — Unrealized @ Report Date —
CGON CG ONCOLOGY INC 6.3%
Value $261M Shares 3,670,206 Share Price $71.05 Est. Cost/Share — Unrealized @ Report Date —
IRON DISC MEDICINE INC 2.4%
Value $98.14M Shares 1,341,862 Share Price $73.14 Est. Cost/Share — Unrealized @ Report Date —
XNCR XENCOR INC 0.9%
Value $39.48M Shares 2,452,138 Share Price $16.10 Est. Cost/Share — Unrealized @ Report Date —
SVRA SAVARA INC 1.8%
Value $76.15M Shares 12,362,205 Share Price $6.16 Est. Cost/Share — Unrealized @ Report Date —
VOR VOR BIOPHARMA INC 2.5%
Value $104M Shares 5,673,078 Share Price $18.41 Est. Cost/Share — Unrealized @ Report Date —
CATX PERSPECTIVE THERAPEUTICS INC 0.6%
Value $26.99M Shares 7,915,567 Share Price $3.41 Est. Cost/Share — Unrealized @ Report Date —
CNTX CONTEXT THERAPEUTICS INC 0.0%
Value $1.486M Shares 2,682,696 Share Price $0.55 Est. Cost/Share — Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS INC 2.6%
Value $110M Shares 11,020,968 Share Price $10.00 Est. Cost/Share — Unrealized @ Report Date —
AGMB AGOMAB THERAPEUTICS NV 0.6%
Value $26.65M Shares 2,053,233 Share Price $12.98 Est. Cost/Share — Unrealized @ Report Date —
SRZN SURROZEN INC 0.9%
Value $38.23M Shares 1,473,101 Share Price $25.95 Est. Cost/Share — Unrealized @ Report Date —
IPSC CENTURY THERAPEUTICS INC 1.0%
Value $43.4M Shares 17,754,430 Share Price $2.44 Est. Cost/Share — Unrealized @ Report Date —
TECX TECTONIC THERAPEUTIC INC 1.0%
Value $41.42M Shares 1,204,891 Share Price $34.37 Est. Cost/Share — Unrealized @ Report Date —
JANX JANUX THERAPEUTICS INC 0.7%
Value $27.49M Shares 1,789,617 Share Price $15.36 Est. Cost/Share — Unrealized @ Report Date —
OCUL OCULAR THERAPEUTIX INC 0.4%
Value $16.18M Shares 1,647,752 Share Price $9.82 Est. Cost/Share — Unrealized @ Report Date —
CGEM CULLINAN THERAPEUTICS INC 0.2%
Value $7.408M Shares 406,786 Share Price $18.21 Est. Cost/Share — Unrealized @ Report Date —
ALEC ALECTOR INC 0.5%
Value $20.1M Shares 10,000,000 Share Price $2.01 Est. Cost/Share — Unrealized @ Report Date —
KOD KODIAK SCIENCES INC 1.4%
Value $56.32M Shares 1,445,538 Share Price $38.96 Est. Cost/Share — Unrealized @ Report Date —
KRRO KORRO BIO INC 0.1%
Value $5.487M Shares 416,301 Share Price $13.18 Est. Cost/Share — Unrealized @ Report Date —
LONA LEONABIO INC 0.1%
Value $4.268M Shares 464,398 Share Price $9.19 Est. Cost/Share — Unrealized @ Report Date —